Literature DB >> 34345567

Impact of Asthma on the Quality of Sleep in Young People.

Akhtar Ali1, Deepa Kumari2, Deepak Kataria3, Fnu Priyanka3, Muhammad Umair Nawaz4, Fnu Pariya4, Rama Kalyani Kavuri5, Sidra Naz6, Amna Jamil7, Faizan Shaukat8.   

Abstract

Introduction Asthma has a negative impact on the quality of life of patients and their families. One of the factors responsible for the low quality of life is poor sleep quality in asthmatic patients. Sleep disturbances, such as difficulty initiating and maintaining sleep, are common in asthma. In this study, we aim to determine the quality of sleep in young asthmatic patients in a local setting. Method This case-control study was conducted in the pulmonology and internal medicine unit of a tertiary care hospital, Pakistan from January 2021 to May 2021. After seeking informed consent, 200 patients with a previously confirmed diagnosis of asthma were enrolled in the study. The control group also included 200 participants. Pittsburgh Sleep Quality Index (PSQI) is an efficient measure of the quality and pattern of sleep. A global PSQI score of ≥5 signifies "poor sleep quality." Results The mean PSQI score was significantly higher in the asthmatic group compared to the control group (6.26 ± 2.01 vs. 3.41 ± 0.50; p-value: <0.0001). The percentage of participants with a PSQI score of ≥5 was significantly higher in the asthmatic group compared to the control group (54.5% vs. 17.0%; p-value: <0.0001). Conclusion Sleep disturbance is very common in young patients with asthma. Poor sleep may interfere with their daily performance, which may further have a negative impact on the quality of life in asthmatic patients. Management of asthma should also include improving sleep quality.
Copyright © 2021, Ali et al.

Entities:  

Keywords:  asthma; impact; quality of life; sleep quality; young patients

Year:  2021        PMID: 34345567      PMCID: PMC8325563          DOI: 10.7759/cureus.16098

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Asthma is a chronic obstructive disease of the respiratory tract [1]. The global burden of asthma has increased over the last two decades whereby it now affects approximately 300 million people worldwide, with a predilection towards industrialized countries. The onset of the disease is mostly early in life, with almost 90% of cases diagnosed before the age of six years [1,2]. It is characterized by the presence of hyper-responsive airways with reversible airway obstruction and inflammation, leading to symptoms of cough, wheeze, breathlessness, and chest tightness [3,4]. Asthma has a great impact on the quality of life (QOL) of patients and their families. The magnitude of this morbidity is affected by several personal factors [5]. One of these factors responsible for the low QOL is poor sleep quality in asthmatic patientsSleep disturbance includes difficulty initiating and maintaining sleep; patients with asthma commonly report frequent awakenings [6-9]. Although nocturnal exacerbations can indicate inadequate asthma control and disturbed sleep, poor sleep has been reported in patients with well-controlled asthma, suggesting that poor sleep may be independent of nocturnal asthma symptoms [6,10]. There are very limited data available in the local and regional settings to assess the impact of asthma on the quality of sleep. Therefore, we aim to determine the impact of asthma on the quality of sleep in asthmatic patients.

Materials and methods

This case-control study was conducted from January 2021 to May 2021. Participants were enrolled from the pulmonology and internal medicine unit of a tertiary care hospital, Pakistan. Informed consent was taken from the participants. Patients with a previously confirmed diagnosis of asthma, of both gender and aged between 10 and 24 years, were enrolled as the study group (n=200). Another 200 participants were enrolled in the study as the control group from the outpatient department. Ethical approval was taken from the institutional review board before enrolling the participants. Pittsburgh Sleep Quality Index (PSQI) is an efficient measure of the quality and pattern of sleep. It assesses sleep quality on seven components, i.e. subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, the use of sleeping medication, and daytime dysfunction. Its scores range from a minimum zero to a maximum of 21. The combined score of all seven components is termed as “global score of PSQI” and a global PSQI score of ≥5 signifies “poor sleep quality.” Its internal consistency and reliability coefficient (Cronbach's alpha) is 0.83 for its seven components [11]. The PSQI score of participants of both groups was compared. Data were entered and analyzed using the Statistical Package for the Social Sciences for Windows, version 22.0 (SPSS, IBM Corp., Armonk, NY, USA). Patients’ demographics were calculated as frequencies and percentages. Numerical data were presented as mean and standard deviation. The comparison of the mean PSQI score between the two groups was done by applying a t-test. Similarly, the comparison of participants with PSQI square equal to more than 5 was done by applying chi-square. A p-value of less than 0.05 was considered significant.

Results

The mean age of participants in the case group was 14 ± 4 years, while in the control group it was 15 ± 4 years. The characteristics, such as age and gender, were comparable between both groups (Table 1).
Table 1

The demographics of the participants

NS: Not Significant

CharacteristicsCase group (n=200)Control group (n=200)P-value
Age groups (in years)
10-17109 (54.5%)107 (53.5%)NS
18-2491 (45.5%)93 (46.5%)
Gender
Male111 (55.5%)109 (54.5%)NS
Female89 (44.5%)91 (45.5%)

The demographics of the participants

NS: Not Significant The mean PSQI score was significantly higher in the asthmatic group compared to the control group (6.26 ± 2.01 vs. 3.41 ± 0.50; p-value: <0.0001). The percentage of participants with a PSQI score of ≥5 was significantly higher in the asthmatic group compared to the control group (54.5% vs. 17.0%; p-value: <0.0001) (Table 2).
Table 2

The comparison of PSQI score of both groups

PSQI: Pittsburgh Sleep Quality Index

PSQI scoreCase group (n=200)Control group (n=200)P-value
Mean score6.26 ± 2.013.41 ± 0.50<0.0001
Participants with ≥5 score109 (54.5%)34 (17.0%)<0.0001

The comparison of PSQI score of both groups

PSQI: Pittsburgh Sleep Quality Index

Discussion

Our study indicates that the quality of sleep in the young asthmatic patients is impaired compared to the control group Mean PSQI score was higher in asthmatic patients compared to the control group. Our study’s mean score was found to be very close to Braido et al., which reported the mean score to be 5.68 ± 3.4 [11]. Moreover, a significantly higher number of asthmatic patients (54.5%) had a PSQI score of ≥5 compared to the control group (17%). Several similar studies in the past have shown results coinciding with our study, with a prevalence of high PSQI scores in asthmatic patients, such as 58.3% [11] and 60% [12]. Several studies have suggested that asthmatic patients are known to have troublesome nights, including not sleeping, waking up in the middle of the night, and early in the morning [7]. Recently, a study including a large sample size of approximately 5,000 patients from 10 European countries concluded that nasal and respiratory factors are correlated with a short duration of sleep (less than six hours) [13]. Disturbed sleep could potentially lead to drowsiness during the day. A Severe Asthma Research Program (SARP) cohort was conducted including 255 patients, 40% of patients with severe asthma presented with complaints of lethargy during the day, and 31% demonstrated a high Epworth Sleepiness Score [14]. This points toward the fact that the patientscognitive abilities and daytime working are affected; however, sufficient data on this aspect were not available as of now in adults. Fitzpatrick et al. analyzed 12 asthmatic patients focusing on their sleep patterns and including a broad spectrum of cognitive properties like the evaluation of short-term memory, focus, and patterns of attention [10]. Cukic et al. suggested that sleep disturbance in asthmatic patients can lead to daytime sleepiness and fatigue, and cognitive impairment [15]. In this small sample size, all patients with nocturnal asthma had disturbed intellectual performance. However, this aspect has been thoroughly investigated in children, and nocturnal asthma has been proven to disturb school performance and attendance. Literature has made it clear that asthma negatively affects sleep quality. This, in turn, affects the quality functioning of the brain and daily day-to-day performance. Based on the results of our study, future studies are required to explore potential treatment options to improve the state of asthma. Improved asthma would eventually solve the problems related to sleep, leading to better cognitive and daily functioning. To the best of our knowledge, this is the first study in our regional setting to study the impact of asthma on sleep quality. However, since the study was conducted in a single institute and city, care should be taken while generalizing the result to a greater population.

Conclusions

Our study indicates poor sleep among asthmatic patients. Poor sleep may interfere with their daily performance, which may further have a negative impact on QOL in asthmatic patients. To mitigate this problem, potential treatment options should be prescribed to help improve the severity of asthma. Treating the basic problem would eventually lead to the development of proper sleeping habits.
  15 in total

Review 1.  The global burden of asthma: executive summary of the GINA Dissemination Committee report.

Authors:  Matthew Masoli; Denise Fabian; Shaun Holt; Richard Beasley
Journal:  Allergy       Date:  2004-05       Impact factor: 13.146

2.  Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries.

Authors:  C Janson; W De Backer; T Gislason; P Plaschke; E Björnsson; J Hetta; H Kristbjarnarson; P Vermeire; G Boman
Journal:  Eur Respir J       Date:  1996-10       Impact factor: 16.671

Review 3.  The role of vitamin D in asthma.

Authors:  Manbir S Sandhu; Thomas B Casale
Journal:  Ann Allergy Asthma Immunol       Date:  2010-03-01       Impact factor: 6.347

4.  Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance.

Authors:  M F Fitzpatrick; H Engleman; K F Whyte; I J Deary; C M Shapiro; N J Douglas
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

5.  Sleep quality in asthma: results of a large prospective clinical trial.

Authors:  John G Mastronarde; Robert A Wise; David M Shade; Christopher O Olopade; Steven M Scharf
Journal:  J Asthma       Date:  2008-04       Impact factor: 2.515

6.  Impact of Sleep Quality on Asthma Control amongst Asthmatics at Federal Medical Centre, Owo, Ondo State.

Authors:  O O Akinwalere; B O Adeniyi; O F Awopeju; G E Erhabor
Journal:  West Afr J Med       Date:  2020-10

7.  Sleep disturbances and asthma control: a real life study.

Authors:  F Braido; I Baiardini; V Ghiglione; O Fassio; A Bordo; S Cauglia; G W Canonica
Journal:  Asian Pac J Allergy Immunol       Date:  2009-03       Impact factor: 2.310

8.  Sleep disorders in patients with bronchial asthma.

Authors:  Vesna Cukic; Vladimir Lovre; Dejan Dragisic
Journal:  Mater Sociomed       Date:  2011

Review 9.  Severe asthma and quality of life.

Authors:  Elham Hossny; Luis Caraballo; Thomas Casale; Yehia El-Gamal; Lanny Rosenwasser
Journal:  World Allergy Organ J       Date:  2017-08-21       Impact factor: 4.084

10.  Respiratory symptoms are more common among short sleepers independent of obesity.

Authors:  Erla Björnsdóttir; Christer Janson; Eva Lindberg; Erna Sif Arnardottir; Bryndís Benediktsdóttir; Judith Garcia-Aymerich; Anne Elie Carsin; Francisco Gómez Real; Kjell Torén; Joachim Heinrich; Dennis Nowak; José Luis Sánchez-Ramos; Pascal Demoly; Sandra Dorado Arenas; Ramon Coloma Navarro; Vivi Schlünssen; Chantal Raherison; Debbie L Jarvis; Thorarinn Gislason
Journal:  BMJ Open Respir Res       Date:  2017-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.